Characterization of HCV Interactions with Toll-Like Receptors and RIG-I in Liver Cells

Background and Aim The aim of this study was to examine the mechanisms of IFN induction and viral escape. In order to accomplish the goal we compared our new hepatoma cell line LH86, which has intact TLR3 and RIG-I expression and responds to HCV by inducing IFN, with Huh7.5 cells which lack those features. Methods The initial interaction of LH86 cells, Huh7.5 cells or their transfected counter parts (LH86 siRIG-I, siTLR3 or siTLR7 and Huh7.5 RIG-I, TLR3 or TLR7) after infection with HCV (strain JFH-1) was studied by measuring the expression levels of IFNβ, TRAIL, DR4, DR5 and their correlation to viral replication. Results HCV replicating RNA induces IFN in LH86 cells. The IFN induction system is functional in LH86, and the expression of the RIG-I and TLR3 in LH86 is comparable to the primary hepatocytes. Both proteins appear to play important roles in suppression of viral replication. We found that innate immunity against HCV is associated with the induction of apoptosis by RIG-I through the TRAIL pathway and the establishment of an antiviral state by TLR3. HCV envelope proteins interfere with the expression of TLR3 and RIG-I. Conclusion These findings correlate with the lower expression level of PRRs in HCV chronic patients and highlight the importance of the PRRs in the initial interaction of the virus and its host cells. This work represents a novel mechanism of viral pathogenesis for HCV and demonstrates the role of PRRs in viral infection.

[1]  G. Hartmann,et al.  Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells. , 2009, Biochimica et biophysica acta.

[2]  M. Villacres,et al.  Defective response to Toll‐like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection , 2007, Journal of viral hepatitis.

[3]  S. Lemon,et al.  Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes* , 2005, Journal of Biological Chemistry.

[4]  D. Nelson,et al.  Hepatitis C virus modulates human monocyte‐derived dendritic cells , 2010, Journal of viral hepatitis.

[5]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[6]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[7]  S. Pestka,et al.  Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene , 2004, Oncogene.

[8]  J. Hiscott,et al.  Essential Role of Interferon Regulatory Factor 3 in Direct Activation of RANTES Chemokine Transcription , 1999, Molecular and Cellular Biology.

[9]  G. Natoli,et al.  A birthday gift for TRADD , 2008, Nature Immunology.

[10]  M. Manns,et al.  Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake , 2005, Gut.

[11]  Ralf Bartenschlager,et al.  E2 of Hepatitis C Virus Inhibits Apoptosis1 , 2005, The Journal of Immunology.

[12]  J. Crawford,et al.  Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. , 2007, Gastroenterology.

[13]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[14]  Shizuo Akira,et al.  Toll‐like Receptor and RIG‐1‐like Receptor Signaling , 2008, Annals of the New York Academy of Sciences.

[15]  D. Nelson,et al.  Stabilized β-catenin promotes hepatocyte proliferation and inhibits TNFα-induced apoptosis , 2004, Laboratory Investigation.

[16]  M. Nishimura,et al.  Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. , 2005, Biological & pharmaceutical bulletin.

[17]  Paul B. Fisher,et al.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Hiscott,et al.  MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.

[19]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Nelson,et al.  Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication , 2005, Virology Journal.

[21]  C. Trautwein,et al.  Involvement of TRAIL and its receptors in viral hepatitis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. , 2004, Laboratory investigation; a journal of technical methods and pathology.

[23]  C. Laxton,et al.  Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection , 2007, Antimicrobial Agents and Chemotherapy.

[24]  A. Bowie,et al.  Viral evasion and subversion of pattern-recognition receptor signalling , 2008, Nature Reviews Immunology.

[25]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[26]  I. Julkunen,et al.  IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.

[27]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[28]  N. Terada,et al.  STAT3 induces anti-hepatitis C viral activity in liver cells. , 2004, Biochemical and biophysical research communications.

[29]  Elina Zorde-Khvalevsky,et al.  Toll‐like receptor 3 signaling attenuates liver regeneration , 2009, Hepatology.

[30]  M. Lai.  Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. , 2002, Gastroenterology.

[31]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[32]  R. Ray,et al.  Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes , 2007, Journal of Virology.

[33]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[34]  K. Kodys,et al.  Impaired expression and function of toll‐like receptor 7 in hepatitis C virus infection in human hepatoma cells , 2010, Hepatology.

[35]  F. Weber.  Interaction of hepatitis C virus with the type I interferon system. , 2007, World journal of gastroenterology.

[36]  Á. Prada,et al.  Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection , 2007, BMC infectious diseases.

[37]  D. Adams,et al.  Following the TRAIL from hepatitis C virus and alcohol to fatty liver , 2005, Gut.

[38]  J. Crawford,et al.  Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[39]  Yuqiong Liang,et al.  Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells , 2009, Journal of Virology.

[40]  Tomasz P. Michalak,et al.  Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro , 2009, Hepatology.

[41]  J. Hiscott,et al.  Multiple signaling pathways leading to the activation of interferon regulatory factor 3. , 2002, Biochemical pharmacology.

[42]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[43]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[44]  K. Schulze-Osthoff,et al.  Apoptosis in hepatitis C virus infection , 2003, Cell Death and Differentiation.

[45]  H. Rosen,et al.  Mechanisms of Disease: HCV-induced liver injury , 2007, Nature Clinical Practice Gastroenterology &Hepatology.

[46]  R. Medzhitov,et al.  Toll signaling: RIPping off the TNF pathway , 2004, Nature Immunology.

[47]  G. Ramadori,et al.  NF-κB-dependent synergistic regulation of CXCL10 gene expression by IL-1β and IFN-γ in human intestinal epithelial cell lines , 2007, International Journal of Colorectal Disease.

[48]  J. Hiscott,et al.  Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression , 2006, Virology Journal.

[49]  L. Malmgaard.  Induction and regulation of IFNs during viral infections. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[50]  J. Hoofnagle,et al.  Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C , 2000, Annals of Internal Medicine.

[51]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[52]  S. Locarnini,et al.  Toll‐like receptors, RIG‐I‐like RNA helicases and the antiviral innate immune response , 2007, Immunology and cell biology.

[53]  A. Bowie,et al.  TLR3 in antiviral immunity: key player or bystander? , 2005, Trends in immunology.

[54]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.